With September revenues reported we are looking at
Post# of 7769
Posted On: 10/06/2014 8:20:16 AM
With September revenues reported we are looking at better than $14.5M for Q3. September's number gives us a $66M Annual Run Rate. The first two weeks of November should be an exciting time for SCRC.
RapiMeds adding to this and "rivaling" compound pharmacy as Mr. Schneiderman stated, will position SCRC as a $100M company.
BB, spot on again!
GO SCRC!!!
RapiMeds adding to this and "rivaling" compound pharmacy as Mr. Schneiderman stated, will position SCRC as a $100M company.
BB, spot on again!
GO SCRC!!!
(0)
(0)ScripsAmerica Inc (SCRC) Stock Research Links
Scroll down for more posts ▼